The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 24, 2018

Filed:

Feb. 03, 2016
Applicant:

Galapagos NV, Mechelen, BE;

Inventors:

Reginald Christophe Xavier Brys, Mechelen, BE;

Luc Nelles, Mechelen, BE;

Nick Ernest Rene Vandeghinste, Mechelen, BE;

Blandine Mille-Baker, CR Leiden, NL;

Michela Angela Tessari, CR Leiden, NL;

Assignee:

GALAPAGOS NV, Mechelen, BE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/48 (2006.01); G01N 33/50 (2006.01); G01N 33/53 (2006.01); C12N 15/113 (2010.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1137 (2013.01); C12N 15/113 (2013.01); C12N 15/1138 (2013.01); G01N 33/5032 (2013.01); G01N 33/6887 (2013.01); C12N 2310/14 (2013.01); G01N 2333/726 (2013.01); G01N 2333/912 (2013.01); G01N 2333/9121 (2013.01); G01N 2333/96486 (2013.01); G01N 2333/96494 (2013.01); G01N 2500/04 (2013.01); G01N 2500/10 (2013.01); G01N 2500/20 (2013.01); G01N 2800/105 (2013.01);
Abstract

The invention relates to the field of medicinal research, cartilage physiology and diseases involving the degeneration of cartilage tissue. More specifically, the invention relates to methods and means for identifying compounds that inhibit catabolic processes in chondrocytes and that decrease the degradation of cartilage and/or ECM. The invention also relates to the compounds that are useful in the treatment of osteoarthritis. The invention also relates to targets, the modulation of which results in a decrease in the degradation of ECM and/or cartilage and decrease inflammation. In addition, the invention relates to compositions and methods for the use thereof in treating conditions that are characterized by the degradation of ECM and/or cartilage and inflammation.


Find Patent Forward Citations

Loading…